Leukemoid reaction with ¹⁸F-FDG PET/CT in ovarian carcinoma

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Mar-Apr;41(2):115-117. doi: 10.1016/j.remnie.2022.01.001. Epub 2022 Feb 20.

Authors

L Reguera Berenguer¹, R Pérez Pascual², J F García García³, J de Santiago García⁴, R Márquez Vázquez⁵, J C Alonso Farto²

Affiliations

¹ Servicio de Medicina Nuclear, ITSS en MD Anderson Cancer Center, Madrid, Spain. Electronic address: Lreguerab@gmail.com.
² Servicio de Medicina Nuclear, ITSS en MD Anderson Cancer Center, Madrid, Spain.
³ Servicio de Anatomía Patológica, MD Anderson Cancer Center, Madrid, Spain.
⁴ Servicio de Ginecología y Obstetricia, MD Anderson Cancer Center, Madrid, Spain.
⁵ Servicio de Oncología Médica, MD Anderson Cancer Center, Madrid, Spain.

PMID: 35193815
DOI: 10.1016/j.remnie.2022.01.001

No abstract available

MeSH terms

Carcinoma, Ovarian Epithelial / pathology
Female
Fluorodeoxyglucose F18
Humans
Leukemoid Reaction* / diagnostic imaging
Leukemoid Reaction* / etiology
Ovarian Neoplasms* / diagnostic imaging
Ovarian Neoplasms* / pathology
Positron Emission Tomography Computed Tomography

Substances

Fluorodeoxyglucose F18